# Kagawa Prefectural Central Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/kagawa-prefectural-central-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 19 |
| Citations | 66,573 |
| City | Takamatsu |
| Country | JP |
| Description | Kagawa Prefectural Central Hospital is a research organisation in Takamatsu, JP. OpenAlex records 2,157 works and 66,573 citations for it. 666 researchers list it as their most recent affiliation. |
| Homepage | http://www.chp-kagawa.jp/ |
| OpenAlex ID | https://openalex.org/I4210153576 |
| Researchers | 666 |
| ROR ID | https://ror.org/05m8dye22 |
| Type | healthcare |
| Works | 2,157 |

## University papers

Showing 12 of 22.

- [Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection](https://scholariq.org/papers/risk-factors-for-cisplatin-induced-nephrotoxicity-and-potential-of-magnesium/)
- [MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations](https://scholariq.org/papers/met-tyrosine-kinase-inhibitor-crizotinib-pf-02341066-shows-differential/)
- [Role of Survivin in EGFR Inhibitor–Induced Apoptosis in Non–Small Cell Lung Cancers Positive for <i>EGFR</i> Mutations](https://scholariq.org/papers/role-of-survivin-in-egfr-inhibitor-induced-apoptosis-in-non-small-cell-lung/)
- [The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells](https://scholariq.org/papers/the-anti-her3-antibody-patritumab-abrogates-cetuximab-resistance-mediated-by/)
- [Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin](https://scholariq.org/papers/overcoming-erlotinib-resistance-in-i-egfr-i-mutation-positive-non-small-cell/)
- [Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition](https://scholariq.org/papers/identification-of-c-src-as-a-potential-therapeutic-target-for-gastric-cancer-and/)
- [Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors](https://scholariq.org/papers/phase-i-study-of-amatuximab-a-novel-monoclonal-antibody-to-mesothelin-in/)
- [1,2:3,4:5,6-Tris(bicyclo\[2.2.2\]octeno)tropylium ion: an all-hydrocarbon carbocation with extraordinary stability](https://scholariq.org/papers/1-2-3-4-5-6-tris-bicyclo-2-2-2-octeno-tropylium-ion-an-all-hydrocarbon/)
- [Analysis of Gene Expression in Mouse 2-Cell Embryos Using Fluorescein Differential Display: Comparison of Culture Environments1](https://scholariq.org/papers/analysis-of-gene-expression-in-mouse-2-cell-embryos-using-fluorescein/)
- [Isolation and properties of hydrocarbon salts](https://scholariq.org/papers/isolation-and-properties-of-hydrocarbon-salts/)
- [Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid β production in Alzheimer’s disease](https://scholariq.org/papers/fibronectin-type-iii-domain-containing-protein-5-interacts-with-app-and/)
- [High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin](https://scholariq.org/papers/high-dose-dexamethasone-plus-antihistamine-prevents-colorectal-cancer-patients/)

## University researchers

- [Kunio Okamoto](https://scholariq.org/researchers/kunio-okamoto/)
- [Masakazu Miyamoto](https://scholariq.org/researchers/masakazu-miyamoto/)

## University top topics

Showing 8 of 25.

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Facial Trauma and Fracture Management](https://scholariq.org/topics/facial-trauma-and-fracture-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.